Stay Updated
For all press requests, please reach out to [email protected].
News and Reports
Fierce Pharma: Teva scores rare partial win in CMS price negotiation appeal
Patients for Affordable Drugs CEO Merith Basey called Tuesday’s Austedo decision a “major victory for patients.” “The court rejected Teva’s core arguments and upheld Medicare’s ability to negotiate a lower price for these drugs,” Basey added. “Today’s ruling helps protect the hard-won progress patients across the country fought for in the face of an industry […]
Press Releases
New video follows three patient advocates as they travel to D.C. to share their stories on Capitol Hill and encourage others to speak up. WASHINGTON, D.C. — August 19, 2026 — Today, on National Patient Advocacy Day, Patients For Affordable Drugs (P4AD) released a new video, Your Voice Is Your Power, celebrating some of the patients whose […]
Press Releases
D.C. Circuit Rejects Teva’s Core Challenges to Medicare Drug Price Negotiation
Patient Advocates Applaud Another Major Legal Victory Protecting Medicare’s Power to Negotiate Lower Drug Prices WASHINGTON, D.C. — The U.S. Court of Appeals for the D.C. Circuit today rejected Teva Pharmaceuticals’ core statutory and constitutional challenges to the Medicare Drug Price Negotiation Program, delivering another significant legal victory for the historic program that is lowering prescription […]
News and Reports
The advocacy group Patients for Affordable Drugs noted in a March report that during the first week of 2026, pharmaceutical companies “increased prices on 64 oncology drugs, with 73% of hikes exceeding inflation.”
News and Reports
Herald-Tribune: Generic drug costs could rise under new tariff plan
“Imposing massive tariffs on generic medicines risks making lower-cost generic drugs millions of Americans rely on more expensive and harder to access,” said Merith Basey, CEO of Patients for Affordable Drugs. “Tariffs of this magnitude could have enormous consequences − raising costs, worsening shortages and putting access to lifesaving medicines at risk.”
News and Reports
News and Reports
Milwaukee Journal Sentinel: Lawmakers must protect, expand Medicare drug cost negotiation
As a patient on Medicare, I rely on my Xarelto prescription to prevent deadly blood clots caused by my rare blood cancer, multiple myeloma and the oral chemotherapy I take daily. These drugs used to cost me anywhere from $15,000 to $21,000 every year for ten years. I’ve had to cobble together grants, decimate my […]
News and Reports
Even so, Merith Basey, the CEO of advocacy organization Patients For Affordable Drugs, expressed concern to Reuters that “Imposing massive tariffs on generic medicines risk making lower-cost generic drugs millions of Americans rely on more expensive and harder to access.”